These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8138948)

  • 1. Drug effects on response-duration differentiation. II: Selective effects of antidepressant drugs.
    Hudzik TJ; McMillan DE
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1335-42. PubMed ID: 8138948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential-reinforcement-of-low-rate 72-second schedule: selective effects of antidepressant drugs.
    O'Donnell JM; Seiden LS
    J Pharmacol Exp Ther; 1983 Jan; 224(1):80-8. PubMed ID: 6848751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant-like effects of 5-hydroxytryptamine1A receptor agonists on operant responding under a response duration differentiation schedule.
    Kinney GG; Griffith JC; Hudzik TJ
    Behav Pharmacol; 1998 Jul; 9(4):309-18. PubMed ID: 10065919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antidepressants in rats trained to discriminate centrally administered isoproterenol.
    Crissman AM; O'Donnell JM
    J Pharmacol Exp Ther; 2002 Aug; 302(2):606-11. PubMed ID: 12130722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant effects assessed using behavior maintained under a differential-reinforcement-of-low-rate (DRL) operant schedule.
    O'Donnell JM; Marek GJ; Seiden LS
    Neurosci Biobehav Rev; 2005; 29(4-5):785-98. PubMed ID: 15893376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of drugs on response duration differentiation. V: differential effects under temporal response differentiation schedules.
    McClure GY; Wenger GR; McMillan DE
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1357-67. PubMed ID: 9190872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tricyclic antidepressant and anticholinergic drugs on fixed-interval responding in the squirrel monkey.
    McKearney JW
    J Pharmacol Exp Ther; 1982 Jul; 222(1):215-9. PubMed ID: 7086700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying the molecular structure of behavior: separate effects of caffeine, cocaine, and adenosine agonists on interresponse times and lever-press durations.
    Newland MC
    Behav Pharmacol; 1997 Feb; 8(1):1-16. PubMed ID: 9832996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus effects of alprazolam and diazepam: generalization to benzodiazepines, antidepressants and buspirone.
    Wettstein JG; Gauthier B
    Behav Pharmacol; 1992 Jun; 3(3):229-237. PubMed ID: 11224120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile.
    Caille D; Bergis OE; Fankhauser C; Gardes A; Adam R; Charieras T; Grosset A; Rovei V; Jarreau FX
    J Pharmacol Exp Ther; 1996 Apr; 277(1):265-77. PubMed ID: 8613929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Predicted pharmacology of an antidepressant].
    Pinder RM
    Encephale; 1981; 7(4 Suppl):371-80. PubMed ID: 7318755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential antidepressant effects of novel tropane compounds, selective for serotonin or dopamine transporters.
    Hemby SE; Lucki I; Gatto G; Singh A; Thornley C; Matasi J; Kong N; Smith JE; Davies HM; Dworkin SI
    J Pharmacol Exp Ther; 1997 Aug; 282(2):727-33. PubMed ID: 9262336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of drugs on response duration differentiation. VI: differential effects under differential reinforcement of low rates of responding schedules.
    McClure GY; McMillan DE
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1368-80. PubMed ID: 9190873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of various classes of antidepressants in behavioral paradigms of despair.
    Kulkarni SK; Dhir A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1248-54. PubMed ID: 17570574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The new antidepressant tetrindole].
    Mashkovskiĭ MD; Glushkov RG; Shvedov VI; Andreeva NI; Golovina SM
    Eksp Klin Farmakol; 1993; 56(2):3-6. PubMed ID: 8348033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A selective test for antidepressant treatments using rats bred for stress-induced reduction of motor activity in the swim test.
    West CH; Weiss JM
    Psychopharmacology (Berl); 2005 Oct; 182(1):9-23. PubMed ID: 16047194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antidepressants on GABA(B) receptor function and subunit expression in rat hippocampus.
    Sands SA; Reisman SA; Enna SJ
    Biochem Pharmacol; 2004 Oct; 68(8):1489-95. PubMed ID: 15451391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant-like properties of some serotonin receptor ligands and calcium channel antagonists measured with the forced swimming test in mice.
    Biała G
    Pol J Pharmacol; 1998; 50(2):117-24. PubMed ID: 9798263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments.
    Paul IA; Nowak G; Layer RT; Popik P; Skolnick P
    J Pharmacol Exp Ther; 1994 Apr; 269(1):95-102. PubMed ID: 8169857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of co-administration of antidepressants and monoamine oxidase inhibitors on 5-HT-related behavior in rats.
    Izumi T; Iwamoto N; Kitaichi Y; Kato A; Inoue T; Koyama T
    Eur J Pharmacol; 2007 Jun; 565(1-3):105-12. PubMed ID: 17400208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.